Compare ARK Genomic Revolution ETF (ARKG) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Tyson Foods, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.28, while Tyson Foods, Inc. trades at $57.78 (market cap $20.36B). The key difference: Tyson Foods, Inc. pays a 3.53% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Tyson Foods, Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | TSN | |
|---|---|---|
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $43.57 | $68.75 |
52-Week Low | $23.09 | $50.72 |
Market Cap | — | $20.36B |
Enterprise Value | — | $27.95B |
Dividend Yield | — | 3.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Tyson Foods (TSN) trades at $57.83, showing modest daily gains. The stock presents mixed signals with a bearish technical outlook but strong analyst support (50% buy ratings) and a consensus price target of $69.75. Recent earnings have beaten expectations in two of the last three quarters, while fundamentals show stable revenue near $54.4 billion but thin net margins of 0.81%. The company maintains dividend payments and is focusing on prepared foods growth.
The investment case balances value metrics like low P/S of 0.37 against profitability challenges. Upside potential exists if margin improvements materialize, but risks include volatile input costs and competitive pressures. The stock appears undervalued relative to analyst targets, suggesting cautious optimism for patient investors despite near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
